Processing your request


please wait...

 | Case Page

 | Case Page |

Case Page

 

Aphria Inc.

Case Summary

Aphria Inc. Securities Litigation

Case Summary

Case Status:    ONGOING    
On or around 05/28/2019 (Ongoing date of last review)

Filing Date: December 05, 2018

According to the Complaint, Aphria Inc. purportedly produces and sells medical cannabis.

The Complaint alleges that during the Class Period, Defendants made statements that were materially false and/or
misleading and failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that the Latin American assets acquired by the Company lacked adequate licenses to operate and were overvalued; (2) that the acquisition of the Latin American assets would enrich the Company’s CEO and other insiders at the expense of shareholders; and (3) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

On March 27, 2019, the Court issued an Order appointing Lead Plaintiff and Counsel. Lead Plaintiff filed an amended Complaint on May 28.

Company & Securities Information

Defendant: Aphria Inc.

COMPANY INFORMATION:

Sector: Healthcare
Industry: Biotechnology & Drugs
Headquarters: Canada

SECURITIES INFORMATION:

Ticker Symbol: APHA
Company Market: New York SE
Market Status: Public (Listed)

About the Company & Securities Data


"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.

First Identified Complaint

Edvin Jakobsen, et al. v. Aphria Inc., et al.

COURT: S.D. New York
DOCKET #: 18-CV-11376
JUDGE: Hon. George B. Daniels
DATE FILED: 12/05/2018
CLASS PERIOD START: 07/17/2018
CLASS PERIOD END: 12/04/2018
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Glancy Prongay & Murray LLP (New York)
    122 East 42nd Street, Suite 2920 , Glancy Prongay & Murray LLP (New York), NY 10168
    (212) 682-5340 (212) 884-0988 ·
  2. Law Offices of Howard G. Smith
    3070 Bristol Pike, Suite 112, Law Offices of Howard G. Smith, PA 19020
    215.638.4847 215.638.4867 ·
First Identified Complaint (FIC) Filings:
No Document Title Filing Date
1 Class Action Complaint for Violations of the Federal Securities Laws 12/05/2018
2 U.S. District Court Civil Docket 12/06/2018
3 Memorandum Decision and Order 03/27/2019

Reference Complaint

In re Aphria Inc. Securities Litigation

COURT: S.D. New York
DOCKET #: 18-CV-11376
JUDGE: Hon. George B. Daniels
DATE FILED: 05/28/2019
CLASS PERIOD START: 07/17/2018
CLASS PERIOD END: 04/12/2019
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Levi & Korsinsky, LLP
    30 Broad Street, 15 1h Floor, Levi & Korsinsky, LLP, NY 10004
    212.363.7500 212.363-7171 ·
Reference Complaint (REF) Filings:
No Document Title Filing Date
1 Amended Complaint for Violation of the Federal Securities Laws 05/28/2019
2 U.S. District Court Civil Docket 05/28/2019

Related District Court Filings

—Related District Court Filings Data is not available
 
 

Cases